ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,188.43
0.15%
US Tech 100
17,621.20
0.06%
Dow Jones
38,945.26
0.24%
Brent Oil
82.545
-1.11%
Bitcoin
63,288.44
0.19%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Hutchmed (china) Limited (HCM) Quote

Hutchmed (china) Limited

Hutchmed (china) Limited (HCM)

HUTCHMED China Limited
Hitachi Construction Machinery Co Ltd
307.00
-3.00
( -0.97% )
Updated: 09:50:22
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
307.00
Bid
307.00
Ask
310.00
Volume
29,877
307.00 Day's Range 315.00
173.60 52 Week Range 338.00
Market Cap
-
Previous Close
310.00
Open
312.00
Last Trade
2977
@
307
(AT)
Last Trade Time
09:50:19
Financial Volume
92,030p
VWAP
308.0282
Average Volume (3m)
72,173
Shares Outstanding
871,256,270
Dividend Yield
-
PE Ratio
-
Earnings Per Share (EPS)
-
Revenue
-
Net Profit
-

About Hutchmed (china) Limited

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.hutch-med.com
Headquarters
Grand Cayman, Cym
Founded
1970
Hutchmed (china) Limited is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HCM. The last closing price for Hutchmed (china) was 310p. Over the last year, Hutchmed (china) shares have traded in a share price range of 173.60p to 338.00p.

Hutchmed (china) currently has 871,256,270 shares outstanding.

HCM Latest News

More News

Hutchmed notes CHMP's positive opinion for fruiquintinib approval

Hutchmed (China) Ltd on Friday said that its partner Takeda Pharmaceutical Co Ltd has been notified that the Committe ...

April 26 2024
Alliance News

Hutchmed (China) Limited Positive CHMP Opinion for Fruquintinib

Hutchmed (China) Limited 26 April 2024   HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda   - If approved in the...

April 26 2024
RNS Regulatory News

Hutchmed (China) Limited Vesting of Awards Under the LTIP

Hutchmed (China) Limited 22 April 2024   Vesting of awards under the Long Term Incentive Plan   Hong Kong, Shanghai & Florham Park, NJ - Monday, April 22, 2024: HUTCHMED (China) Limited...

April 22 2024
RNS Regulatory News

Hutchmed (China) Limited 2023 Annual Report and Notice of AGM

Hutchmed (China) Limited 08 April 2024       2023 Annual Report and Notice of Annual General Meeting   Hong Kong, Shanghai, & Florham Park, NJ - Monday, April 8, 2024: HUTCHMED (China...

April 08 2024
RNS Regulatory News

Hutchmed (China) Limited Data to be Presented at AACR Congress 2024

Hutchmed (China) Limited 05 April 2024   Press Release   HUTCHMED Highlights Data to be Presented at AACR Congress 2024     Hong Kong, Shanghai & Florham Park, NJ - Friday, April 5, 2024:...

April 05 2024
RNS Non-Regulatory

Hutchmed endometrial cancer treatment application accepted for review

Hutchmed (China) Ltd on Tuesday jointly announced with Innovent Biologics that their new drug application for the com ...

April 02 2024
Alliance News

Hutchmed (China) Limited HUTCHMED and Innovent Announce NDA Acceptance

Hutchmed (China) Limited 02 April 2024   Press Release   HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of...

April 02 2024
RNS Non-Regulatory

Hutchmed lung cancer treatment accepted for review in China

Hutchmed (China) Ltd on Thursday said its supplemental new drug application for savolitinib has been accepted for rev ...

March 28 2024
Alliance News

Hutchmed begins registration stage for sovleplenib phase 2/3 trial

Hutchmed (China) Ltd on Friday said it initiated the registration stage of the phase 2/3 clinical trial for sovleplen ...

March 22 2024
Alliance News

*CORRECT: Hutchmed China initiates registration for phase 3 trials of sovleplenib

...

March 22 2024
Alliance News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
110.326797385621306316292107545305.9088389DE
42910.431654676327831626092335292.16306355DE
1286.539.2290249433220.5316202.572173273.66115727DE
26-4.5-1.44462279294311.5324.5190.478576274.31094126DE
5256.522.5548902196250.5338173.669779267.46490049DE
156-70-18.5676392573377656130112929332.93219767DE
260-142.00000669-31.6258362081449.0000066965613099328353.79902654DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MTCMMTec Inc
$ 4.4273
(92.49%)
9.72M
NUWENewellis Inc
$ 0.2739
(60.18%)
64.91M
GSUNGolden Sun Health Technology Group Ltd
$ 4.52
(55.86%)
2.85M
CMNDClearmind Medicine Inc
$ 1.6285
(39.19%)
36.74M
AIREreAlpha Tech Corporation
$ 1.155
(34.85%)
13.99M
GPGreenPower Motor Company Inc
$ 1.25
(-31.32%)
492.13k
AGRIAgriFORCE Growing Systems Ltd
$ 0.10
(-30.75%)
1.68M
NUVOHoldco Nuvo Group DG Ltd
$ 3.80
(-27.62%)
431k
TACTTransAct Technologies Inc
$ 3.97
(-22.91%)
47.01k
BTBDBT Brands Inc
$ 1.25
(-21.38%)
4.32k
NUWENewellis Inc
$ 0.2726
(59.42%)
64.92M
FFIEFaraday Future Intelligent Electric Inc
$ 0.0499
(20.82%)
62.8M
CMNDClearmind Medicine Inc
$ 1.6279
(39.14%)
36.75M
NKLANikola Corporation
$ 0.5898
(-7.47%)
34.7M
PEGYPineapple Energy Inc
$ 0.058
(9.02%)
20.55M

Discussion

View Full Feed
WeTheMarket WeTheMarket 4 minutes ago
https://staticapp.icpsc.com/icp/resources/mogile/1085472/eb1784ff7066afd7343dc4a47d244941.png

Join us TOMORROW for a FREE SFT Webinar!

Register at https://nafa.users.membersuite.com/events/0bf51f0a-0078-cc90-4da9-0b469a861b32/details

Hydrogen: Considerat
PLUG
ap17 ap17 4 minutes ago
TRUE!
BTCUSD
Sirpeter Sirpeter 4 minutes ago
Global leaders?...lol,lol,...LMAO!!!
CBIA
diggitydoodle diggitydoodle 4 minutes ago
RNVA restacking underway. From 102 mill to 113 mill in two minutes.
More restacking coming, no matter what the glorious accumulation.
RNVA!!$$$$$??????
RNVA
Tree Tree 4 minutes ago
I hope that you don't. Hopefully it loses steam
Jetmek_03052 Jetmek_03052 5 minutes ago
Ouch? This is up almost $100/share in 4 trading days. It is heavily traded and volatile. It goes down 30 minutes into the trading day and you give it an "ouch"?

Let's see what happens by the end of the day. Yup, it may stay down. Or it may go up $30-$40 a share! That is NVDA.
NVDA
Golden Cross Golden Cross 5 minutes ago
$RDAR .0011 Printing! Strong Accumulation Underway!

https://investorshub.advfn.com/uimage/uploads/2024/5/6/egtjv01-1.png
RDAR
kytrader77 kytrader77 5 minutes ago
I thought you said you were going back away for a while? We enjoyed the silence.
SEV
JPetroInc JPetroInc 5 minutes ago
blah blah blah…

only thing that’s serious around here …

is amount of OCD’’s running the looney bin…!

BAF MONI…!

MOO stunad
MONI
RedSox04 RedSox04 5 minutes ago
You first been doing my part, you just complain
CBDW
Tree Tree 5 minutes ago
Holy heck!!!
We had one go down our street in the summer of 1978. Fortunately, no damage was done
Two weeks ago was the first time that I actually took cover in years
runncoach runncoach 5 minutes ago
Agreed
SNPX
Arti3boy Arti3boy 5 minutes ago
Early when it was trading I saw 31 million on the bid, did anyone else see that?
NSAV
pdmihopefull pdmihopefull 5 minutes ago
Good luck with that!!!... kgkg needs income/profit statementsss....I would not care if you called it " bat CACA"…as long as the consumer loves it... and keeps buying it....
KGKG
JettaR JettaR 5 minutes ago
Well do it them!
CBDW
rayovac812 rayovac812 5 minutes ago
It is better to fail at originality than to succeed at imitation?

1. So quoting sayings is original? 2. If you are imitating someone that has consistently supported vision through the thick and thin, which of you has been a wet paper airplane? Succeeding at imitation is all in the ch
KBLB
al44 al44 5 minutes ago
Bernie Sanders wants to raise your prescription costs

By Dr. Ben Tapper

Responding to a recent Yale study, which found that drug manufacturer Novo Nordisk is selling the popular type two diabetes drug Ozempic, which costs less than $5 to produce, for nearly $1,000, Sen.
PBM
tw0122 tw0122 6 minutes ago
GSUN 7.25 + 135% the sun is bright. Time to cash out and don’t look back
GSUN
stock1ace1 stock1ace1 6 minutes ago
IMAB $1.87 Ripp!! Golden cross complete
IMAB
Golden Cross Golden Cross 6 minutes ago
500% you missed out on...Keep on bashing...
RDAR
Nemesis18 Nemesis18 6 minutes ago
DCVAX-L has not met the high bar required by the MHRA for a new cancer vaccine.
It was allowed to have a regulatory shot at Marketing Approval, mostly because of political pressure, but it has fallen short, in my opinion.

Further, I believe that NWBO Already know this to be the
NWBO
Twilson Twilson 6 minutes ago
I was in spy puts when you posted what is the bad news?
reko01 reko01 6 minutes ago
The release survey/geophys results show VERY promising #GOLD ground for $ACRL. Early drill tests showed gold levels up to 7g/ton. Currently waiting on the full assays of the drill holes. Their neighbor $AEM is closely watching $ACRL here.
ACRL AEM
Porch Honkey Porch Honkey 6 minutes ago
How many more shares does the toxic note holder have left to dump, does anyone know?
GTCH
georgie18 georgie18 6 minutes ago
AIRE...$1.04...Looking for the Gap Fill...🥳
AIRE

Your Recent History

LSE
HCM
Hutchmed (china)
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved